Press Releases
PatentVest makes the news because of their revolutionary approaches to solving global challenges. If you have needs beyond these resources, please contact [email protected]
Invizyne Technologies Announces Name Change to eXoZymes, Inc. and New Ticker Symbol
Trading Under New Ticker of “EXOZ” Expected to Begin February 12, 2025. Monrovia, CA, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Today, Invizyne Technologies, Inc., (NASDAQ: IZTC) ("Invizyne"), a leading designer of cell-free, enzyme-based biomanufacturing systems to produce...
HeartBeam Achieves Major Milestone with FDA Submission for its Groundbreaking 12-Lead ECG Synthesis Software
SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced it has submitted a 510(k) application to the U.S. Food and Drug...
HeartBeam Announces FDA Clearance for At-Home, High-Fidelity Heart Monitoring Technology
First cable-free, ambulatory ECG that captures the heart’s electrical signals from three distinct directions for high-fidelity data collection and advanced diagnostics Patients can have the credit card-sized device with them at all times, ready to record an ECG...
HeartBeam Announces Positive Data from Two Studies at Prestigious American Heart Association Conference
The studies further strengthen HeartBeam’s body of clinical evidence for its portable, cable-free, credit card-sized device that is designed to be capable of synthesizing a 12-lead ECG The first study is a pilot study demonstrating similar performance of HeartBeam’s...
MDB Capital Holdings to Host Third Quarter 2024 Results Conference Call on Thursday November 21, 2024, at 4:30 p.m. Eastern Time
Addison, Texas, Nov. 15, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading deep technology companies, plans to host a Zoom webinar on Thursday November 21, 2024 at 4:30 p.m....
Invizyne Technologies Begins Trading on NASDAQ
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC" Monrovia, CA, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important...
Invizyne Technologies to Begin Trading on NASDAQ on November 13, 2024
Next Generation Synthetic Biology Company Will Trade Under Ticker Symbol "IZTC" Monrovia, CA, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Invizyne Technologies, Inc., a leading designer of cell-free, enzyme-based biomanufacturing systems to produce commercially important...
HeartBeam Named “Rising Star” at the 6th Annual Digital Health Hub Foundation Awards
Company Receives Top Honors in the ‘Home Health Diagnostic’ Category for its Groundbreaking Technology that Captures the Heart’s Electrical Signals from Three Dimensions SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology...
MDB Capital Teams with TCA Venture Group to Bring New Insights and Public Venture Opportunities to Angel Investors
Addison, TX, Oct. 16, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC (NASDAQ: MDBH) ("MDB"), a public venture platform focused on launching category-leading deep technology companies, announced its sponsorship of TCA Venture Group, ("TCA") one of the largest and...
ClearSign Technologies Announces Order for Multi Heater Project for Texas Petrochemical Facility
Project Comprised of 26 ClearSign Core™ Process Burners in Four Heaters Order Received from Birwelco USA Inc. for Fortune 500 Global Chemical Company TULSA, Okla., July 17, 2024 /PRNewswire/ -- ClearSign Technologies Corporation (Nasdaq: CLIR) ("ClearSign" or the...
MDB Capital Announces Record Date and Expected Timing for Initial Public Offering for Invizyne Technologies
Addison, Texas, July 11, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) ("MDB"), a public venture platform focused on launching category-leading deep technology companies, today announces the record date, allocation preference, and expected...
MDB Capital Collaborates with Mayo Clinic to Advance Anti-Senescence Platform
ADDISON, Texas, July 08, 2024 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) ("MDB"), a public venture platform focused on launching category-leading deep technology companies, today announced a collaboration through a patent and know-how agreement with...